{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:24:32Z","timestamp":1789118672870,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Demand for attention-deficit hyperactivity disorder (ADHD) services has increased substantially across health systems, placing pressure on specialist services and contributing to prolonged waiting times and inconsistent medication monitoring. Pharmacists have established expertise in medicines optimisation and, in some settings, are authorised to prescribe. Yet their role within ADHD care pathways remains poorly characterised.Kindly check and confirm the inserted city name in affiliations 3, 5, 6 and country name in affiliation 6 are correct and amend if necessary.Changes have been made, where necessary.\u00a0\u00a0<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This scoping review aims to map the existing empirical evidence on pharmacist involvement in ADHD services, synthesise reported roles and impacts, and identify key evidence gaps to inform future research and service development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A scoping review was conducted in accordance with the Arksey and O\u2019Malley framework and reported using PRISMA-ScR guidance. Six databases (PubMed, PsycINFO, Embase, CINAHL, Scopus, and Web of Science) were searched from inception to December 2025. Empirical studies evaluating implemented pharmacist involvement in ADHD services were included, irrespective of study design. Data were charted and synthesised narratively across domains relating to clinical care, service delivery, economic outcomes, and barriers to implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirteen studies were included, published between 2008 and 2025, primarily from the United States and the United Kingdom. Most were service evaluations or pre-post studies, with one randomised trial. Pharmacists were involved in a broad range of activities, including medication initiation, titration, monitoring, follow-up, patient education, and service governance, often as independent prescribers or within collaborative multidisciplinary models. Reported impacts included improved adherence to recommended monitoring standards, increased service capacity, reduced waiting times, and more efficient workforce utilisation, with some evidence of potential cost savings. However, outcome measures varied widely, and patient-reported outcomes, comparative effectiveness, and implementation processes were inconsistently examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This review identifies a small but expanding evidence base indicating potential roles for pharmacists in ADHD services, particularly in medicines management and service delivery. However, the absence of clearly defined service models and limited comparative and implementation-focused evidence constrain wider adoption across health systems. Further research is needed to inform scalable and sustainable approaches to pharmacist integration in ADHD care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11096-026-02184-2","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:11:29Z","timestamp":1784121089000},"page":"1812-1826","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Roles and impacts of pharmacists in attention-deficit hyperactivity disorder services: a scoping review"],"prefix":"10.1007","volume":"48","author":[{"given":"Muhammad Umair","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atta Abbas","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian Chi-Kei","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Maidment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"2184_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jad.2023.07.071","volume":"339","author":"G Ayano","year":"2023","unstructured":"Ayano G, Demelash S, Gizachew Y, et al. The global prevalence of attention deficit hyperactivity disorder in children and adolescents: an umbrella review of meta-analyses. J Affect Disord. 2023;339:860\u20136.","journal-title":"J Affect Disord"},{"key":"2184_CR2","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.11.04009","volume":"11","author":"P Song","year":"2021","unstructured":"Song P, Zha M, Yang Q, et al. The prevalence of adult attention-deficit hyperactivity disorder: a global systematic review and meta-analysis. J Glob Health. 2021;11:04009.","journal-title":"J Glob Health"},{"key":"2184_CR3","unstructured":"NICE. Attention deficit hyperactivity disorder: diagnosis and management. National Institute for Health and Care Excellence, 2018. https:\/\/www.nice.org.uk\/guidance\/ng87. Accessed 26 Jan 2026."},{"issue":"1","key":"2184_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjment-2024-301384","volume":"28","author":"MU Khan","year":"2025","unstructured":"Khan MU, Hasan SS. Socioeconomic status and prescribing of ADHD medications: a study of ICB-level data in England. BMJ Ment Health. 2025;28(1):e301384.","journal-title":"BMJ Ment Health"},{"key":"2184_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fsoc.2020.535125","volume":"5","author":"F Ortega","year":"2020","unstructured":"Ortega F, M\u00fcller MR. Global mental health and pharmacology: the case of attention deficit and hyperactivity disorders in Brazil. Front Sociol. 2020;5:535125.","journal-title":"Front Sociol"},{"issue":"10","key":"2184_CR6","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1097\/MS9.0000000000001179","volume":"85","author":"G Olatunji","year":"2023","unstructured":"Olatunji G, Faturoti O, Jaiyeoba B, et al. Navigating unique challenges and advancing equitable care for children with ADHD in Africa: a review. Ann Med Surg. 2023;85(10):4939\u201346.","journal-title":"Ann Med Surg"},{"key":"2184_CR7","unstructured":"Silk S. Systemic issues in the treatment of ADHD in New Zealand. University of Canterbury, 2025. https:\/\/ir.canterbury.ac.nz\/server\/api\/core\/bitstreams\/b952ae48-e927-46a6-8feb-4459a86359aa\/content. Accessed 23 Jan 2026."},{"key":"2184_CR8","unstructured":"NHS Taskforce. Report of the independent ADHD Taskforce: Part 1. NHS England. https:\/\/www.england.nhs.uk\/long-read\/report-of-the-independent-adhd-taskforce-part-1\/. Accessed 27 Jan 2026."},{"key":"2184_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.649399","volume":"12","author":"S Young","year":"2021","unstructured":"Young S, Asherson P, Lloyd T, et al. Failure of healthcare provision for attention-deficit\/hyperactivity disorder in the United Kingdom: a consensus statement. Front Psychiatry. 2021;12:649399.","journal-title":"Front Psychiatry"},{"issue":"S1","key":"2184_CR10","first-page":"S183","volume":"7","author":"E Davies","year":"2021","unstructured":"Davies E, Khan M, Jones C. Do you mind if I take your blood pressure? Physical health monitoring of children and young people on ADHD medication amidst a pandemic. BJPsych Open. 2021;7(S1):S183\u20134.","journal-title":"BJPsych Open"},{"key":"2184_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/ijpp\/riaf124","author":"AA Naqvi","year":"2025","unstructured":"Naqvi AA, Khan MU, Karim L, et al. The role of pharmacists in managing common mental health conditions in UK primary and secondary care settings: a scoping review. Int J Pharm Pract. 2025. https:\/\/doi.org\/10.1093\/ijpp\/riaf124.","journal-title":"Int J Pharm Pract"},{"issue":"4","key":"2184_CR12","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.1016\/j.japh.2021.01.029","volume":"61","author":"L Pohl","year":"2021","unstructured":"Pohl L, El-Kurdi R, Selinger R, et al. Implementation of a community-based pharmacist-run attention deficit hyperactivity disorder clinic in a college health center. J Am Pharm Assoc. 2021;61(4):S178\u201383.","journal-title":"J Am Pharm Assoc"},{"key":"2184_CR13","unstructured":"Shah C, Umaru N, Adams E, et al. Assessing the integration of pharmacist independent prescribers in child and adolescent mental health services. Pharm J. 2021. https:\/\/pharmaceutical-journal.com\/article\/research\/assessing-the-integration-of-pharmacist-independent-prescribers-in-child-and-adolescent-mental-health-services. Accessed 26 Jan 2026."},{"key":"2184_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2019-nppc.3","volume":"104","author":"C O\u2019Brien","year":"2019","unstructured":"O\u2019Brien C. O3 Developing a pharmacist prescribing role within child and adolescent mental health services (CAMHS). Arch Dis Child. 2019;104:e2.","journal-title":"Arch Dis Child"},{"key":"2184_CR15","first-page":"629","volume-title":"Encyclopedia of pharmacy practice and clinical pharmacy","author":"MU Khan","year":"2019","unstructured":"Khan MU, Aslani P. Attention-deficit hyperactivity disorder management and the role of the pharmacist. In: Encyclopedia of pharmacy practice and clinical pharmacy. Elsevier; 2019. p. 629\u201339."},{"issue":"3","key":"2184_CR16","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.3390\/ijerph20032754","volume":"20","author":"MH Elnaem","year":"2023","unstructured":"Elnaem MH, AbouKhatwa MM, Elrggal ME, et al. Attention deficit hyperactivity disorder: What are pharmacists\u2019 roles and associated outcomes? Int J Environ Res Public Health. 2023;20(3):2754.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"2184_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/jac5.1880","volume":"7","author":"DL Stutzman","year":"2024","unstructured":"Stutzman DL, Leiby LE, Temelie A, et al. Role of board-certified psychiatric pharmacists in child and adolescent psychiatry. J Am Coll Clin Pharm. 2024;7(2):149\u201359.","journal-title":"J Am Coll Clin Pharm"},{"issue":"1","key":"2184_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O\u2019malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19\u201332.","journal-title":"Int J Soc Res Methodol"},{"issue":"10","key":"2184_CR19","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","volume":"18","author":"MD Peters","year":"2020","unstructured":"Peters MD, Marnie C, Tricco AC, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020;18(10):2119\u201326.","journal-title":"JBI Evid Synth"},{"issue":"7","key":"2184_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"issue":"11","key":"2184_CR21","first-page":"1156","volume":"31","author":"TA Lieu","year":"2025","unstructured":"Lieu TA, Parry D, deLaunay A, et al. Pharmacist care for attention-deficit\/hyperactivity disorder electronic medication refills: a cluster randomized trial. J Manag Care Spec Pharm. 2025;31(11):1156\u201365.","journal-title":"J Manag Care Spec Pharm"},{"key":"2184_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.7812\/TPP\/19.122","volume":"24","author":"R Huang","year":"2020","unstructured":"Huang R, Ridout SJ, Harris B, et al. Pharmacist medication management of adults with attention deficit: an alternative clinical structure. Perm J. 2020;24:19\u201322.","journal-title":"Perm J"},{"issue":"5","key":"2184_CR23","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1016\/j.japh.2020.03.020","volume":"60","author":"T Casey","year":"2020","unstructured":"Casey T, Johnson C, Love D. Adult attention deficit hyperactivity disorder clinic: an interprofessional collaboration. J Am Pharm Assoc. 2020;60(5):S113\u20137.","journal-title":"J Am Pharm Assoc"},{"issue":"5","key":"2184_CR24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.9740\/mhc.2020.09.296","volume":"10","author":"KC Lee","year":"2020","unstructured":"Lee KC, Kim E, Kim J, et al. Development of an innovative adult attention-deficit hyperactivity disorder clinic. Ment Health Clin. 2020;10(5):296\u2013300.","journal-title":"Ment Health Clin"},{"issue":"4","key":"2184_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1177\/1059840508319629","volume":"24","author":"TJ Reutzel","year":"2008","unstructured":"Reutzel TJ, Desai A, Workman G, et al. Medication management in primary and secondary schools: evaluation of mental health related in-service education in local schools. J Sch Nurs. 2008;24(4):239\u201348.","journal-title":"J Sch Nurs"},{"issue":"7","key":"2184_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.sapharm.2025.03.003","volume":"21","author":"QD Alfredson","year":"2025","unstructured":"Alfredson QD, Olkiewicz HA, Ose M. Outcomes of a primary care pediatric mental and behavioral health pharmacist consult service within a tertiary pediatric health system. Res Social Adm Pharm. 2025;21(7):523\u20137.","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"2184_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/ejhpharm-2016-001058","volume":"25","author":"R Lyon","year":"2018","unstructured":"Lyon R, Brown G. A naturalistic evaluation of the financial benefits of employing a mental health pharmacist to work with child and adolescent mental health services. Eur J Hosp Pharm. 2018;25(1):48\u201352.","journal-title":"Eur J Hosp Pharm"},{"issue":"6","key":"2184_CR28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00228-010-0790-9","volume":"66","author":"M Tobaiqy","year":"2010","unstructured":"Tobaiqy M, Stewart D, Helms PJ, et al. A pilot study to evaluate a community pharmacy\u2013based monitoring system to identify adverse drug reactions associated with paediatric medicines use. Eur J Clin Pharmacol. 2010;66(6):627\u201332.","journal-title":"Eur J Clin Pharmacol"},{"key":"2184_CR29","unstructured":"Allen S, Allsopp S, Khundakar M. A pilot of pharmacist support to the Attention deficit hyperactivity disorder (ADHD) adult team at Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust (CNTW). In: Great North Pharmacy Research Collaborative Conference, 2025. Abstract 64."},{"issue":"4","key":"2184_CR30","doi-asserted-by":"publisher","first-page":"e283","DOI":"10.1097\/DBP.0000000000001291","volume":"45","author":"N Watthanathiraphapwong","year":"2024","unstructured":"Watthanathiraphapwong N, Traipidok P, Charleowsak P, et al. Reducing stimulant prescribing error: a quality improvement initiative in pediatric outpatient setting. J Dev Behav Pediatr. 2024;45(4):e283\u201392.","journal-title":"J Dev Behav Pediatr"},{"issue":"4","key":"2184_CR31","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/jac5.1245","volume":"3","author":"G Sachdev","year":"2020","unstructured":"Sachdev G, Kliethermes MA, Vernon V, et al. Current status of prescriptive authority by pharmacists in the United States. J Am Coll Clin Pharm. 2020;3(4):807\u201317.","journal-title":"J Am Coll Clin Pharm"},{"issue":"9","key":"2184_CR32","doi-asserted-by":"publisher","first-page":"352","DOI":"10.12968\/jprp.2021.3.9.352","volume":"3","author":"A Armstrong","year":"2021","unstructured":"Armstrong A, Manfrin A, Gibson J. Non-medical prescribing in primary care in the United Kingdom: an overview of the current literature. J Prescr Pract. 2021;3(9):352\u201361.","journal-title":"J Prescr Pract"},{"key":"2184_CR33","unstructured":"PDA. One in three pharmacists now Independent Prescribers \u2013 A significant milestone, but challenges persist. The Pharmacists\u2019 Defence Association, 2025. https:\/\/www.the-pda.org\/one-in-three-pharmacists-now-independent-prescribers-a-significant-milestone-but-challenges-persist\/. Accessed 26 Jan 2026."},{"issue":"8","key":"2184_CR34","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1111\/jan.15658","volume":"79","author":"S MacVicar","year":"2023","unstructured":"MacVicar S, Paterson RE. Characteristics of prescribing activity within primary care in Scotland 2013\u20132022 of general practitioners, nurse, pharmacist and allied health prescribers: a retrospective cross-sectional study. J Adv Nurs. 2023;79(8):3092\u2013101.","journal-title":"J Adv Nurs"},{"key":"2184_CR35","doi-asserted-by":"publisher","first-page":"e085875","DOI":"10.1136\/bmj-2025-085875","volume":"391","author":"CJ Gosling","year":"2025","unstructured":"Gosling CJ, Garcia-Argibay M, De Prisco M, et al. Benefits and harms of ADHD interventions: umbrella review and platform for shared decision making. BMJ. 2025;391:e085875.","journal-title":"BMJ"},{"issue":"1","key":"2184_CR36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12875-025-02787-0","volume":"26","author":"AH Hassan","year":"2025","unstructured":"Hassan AH, Barry HE, Hughes CM. Perspectives of patients on the role of general practice pharmacists: a systematic review and meta-synthesis of qualitative studies. BMC Prim Care. 2025;26(1):90.","journal-title":"BMC Prim Care"},{"issue":"3","key":"2184_CR37","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/wps.21374","volume":"24","author":"S Cortese","year":"2025","unstructured":"Cortese S, Bellgrove MA, Brikell I, et al. Attention-deficit\/hyperactivity disorder (ADHD) in adults: evidence base, uncertainties and controversies. World Psychiatry. 2025;24(3):347\u201371.","journal-title":"World Psychiatry"},{"issue":"1","key":"2184_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1192\/bjb.2023.88","volume":"48","author":"MC Smith","year":"2024","unstructured":"Smith MC, Mukherjee RA, M\u00fcller-Sedgwick U, et al. UK adult ADHD services in crisis. BJPsych Bulletin. 2024;48(1):1\u20135.","journal-title":"BJPsych Bulletin"},{"key":"2184_CR39","first-page":"1","volume":"25","author":"H Tuomainen","year":"2026","unstructured":"Tuomainen H, Appleton R, Dieleman GC, et al. Transitions from child to adult mental health care: the evidence-base for ESCAP guidance for clinicians. Eur Child Adolesc Psychiatry. 2026;25:1\u201323.","journal-title":"Eur Child Adolesc Psychiatry"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02184-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02184-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02184-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:58:47Z","timestamp":1789117127000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-026-02184-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2184"],"URL":"https:\/\/doi.org\/10.1007\/s11096-026-02184-2","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"14 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional ethics approval was not required for this scoping review.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent to publish.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}